• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

    2.570 +0.060 (+2.39%)
    Streaming Delayed Price Updated: 1:15 PM EDT, Mar 10, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 79,344
    Open 2.530
    Bid (Size) 2.570 (200)
    Ask (Size) 2.610 (300)
    Prev. Close 2.510
    Today's Range 2.500 - 2.705
    52wk Range 0.6200 - 3.080
    Shares Outstanding 124,094,390
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
    Veteran sales leader with proven proteomics and life sciences track record from Olink and SomaLogic joins Nautilus to accelerate commercial progress of its Voyager Platform 
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus (NAUT) Q4 2025 Earnings Call Transcript ↗
    Nautilus (NAUT) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings

    Performance

    YTD
    +34.6%
    +34.6%
    1 Month
    +19.0%
    +19.0%
    3 Month
    +26.6%
    +26.6%
    6 Month
    +266.6%
    +266.6%
    1 Year
    +125.4%
    +125.4%

    More News

    Read More
    Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway ↗
    Via Chartmill
    News headline image
    Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Earnings Scheduled For October 28, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For July 31, 2025 ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Which stocks are moving on Monday? ↗
    Via Chartmill
    News headline image
    Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Nautilus Biotechnology Reports Third Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Thermo Fisher Scientific Soars on Strategic Wins, Market Optimism
    Via MarketMinute
    Topics Artificial Intelligence Economy Government
    News headline image
    Presenting at the Investor Summit Q3 2025 on September 16; Watch the Live Stream for Free
    Via ACCESS Newswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Nautilus Biotechnology to Participate in Upcoming September Investor Conferences
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire
    News headline image
    Nautilus Biotechnology Announces Agreement with the Allen Institute, Further Validating its Approach to Single-Molecule Proteomics
    From Nautilus Biotechnology Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?
    Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.
    What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?
    Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?
    The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market
    What is the current price of Nautilus Biotechnology, Inc. - Common Stock?
    The current price of Nautilus Biotechnology, Inc. - Common Stock is 2.570
    When was Nautilus Biotechnology, Inc. - Common Stock last traded?
    The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 03/10/26 01:15 PM ET
    What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?
    The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 318.92M
    How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?
    Nautilus Biotechnology, Inc. - Common Stock has 319M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.